Hershey Reverses Chocolate Changes After Reese’s Cup Inventor’s Grandson Called Them Out Online

Hershey committed to revert affected candies to classic milk chocolate and real peanut butter with a rollout starting next year and a full move by 2027, plus a transition to all-natural colors and a planned enhancement to Kit-Kat. The pledge follows viral consumer backlash led by Brad Reese and admissions that formula tweaks were made on some seasonal/minor SKUs as cocoa prices rose, while core Reese's Cups were unchanged. This is primarily a reputational remediation likely to curb short-term consumer churn but is unlikely to materially alter company fundamentals—expect modest, short-lived share moves (roughly 1–3%) tied to sentiment rather than durable earnings revisions.

Analysis

The immediate investor read is reputation risk for premium confectionery brands; the non-obvious channel is durable erosion of trial rates at high-frequency impulse points (c-stores, checkout lanes). If even 1–2% of repeat buyers switch away for six months, that translates into a visible top-line swing for flagship SKUs given their margin intensity and limited promotional buffers.

Operationally, a pivot back to higher-quality inputs will tighten upstream markets before the end consumer notices. Suppliers of cocoa, dairy solids and natural colorants are capacity-constrained on seasonal cycles; a reversion in formulation concentrated across many SKUs could create a lumpy procurement spike that compresses gross margins by tens to low hundreds of basis points until sourcing and co-manufacturing are rebalanced.

Competitors and ingredient processors are the indirect beneficiaries: branded rivals can buy shelf momentum during the short-term trust gap while processors (large cocoa grinders and dairy ingredient merchants) capture higher margin through spot premiums. Conversely, private-label and margin-focused players can grow share if price-led reformulations force premium brands to ration or raise retail pricing.

Consensus is likely oscillating between headline-driven panic and reassurance; both underplay the cost-of-reversion and the timing risk embedded in supply chains. The key catalysts to watch are (a) the company’s incremental gross-margin guidance, (b) contract re-ups with major co-packers, and (c) cocoa/dairy spot moves — any one can flip market expectations within 30–180 days.

Key Decisions for Investors

• Buy HSY on a sentiment-driven pullback >6% from current levels (or into the next quarterly print). Timeframe 6–12 months; target 12–18% upside if management shows credible cost plan or sales stabilization. Hard stop at 6% downside to limit brand-reputation tail risk.
• Pair trade: Long MDLZ (Mondelez) vs short HSY on a 3–9 month horizon if retailer share-gain data (IRI/Nielsen) shows accelerated defections from key SKUs. Expect 6–12% gross relative outperformance for MDLZ if consumers favor non-controversial alternatives; cap exposure size to 1–2% portfolio to account for mean-reversion.
• Long ingredient processors: initiate a 6–18 month position in Barry Callebaut (SIX:BARN) to play higher cocoa-processing demand and spot premiums. Target 15–25% upside if spot cocoa tightens; risk is demand deceleration or a cocoa crop surprise that collapses spreads.
• Options hedge/spec: buy a 9–12 month HSY call spread (ATM buy / ~10% OTM sell) sized as a 0.5–1% notional portfolio bet to capture recovery while capping premium outlay. This yields asymmetric upside if sentiment normalizes without committing large capital to outright stock exposure.